Click for best price
Opioid Induced Constipation Drugs Market Size, Share 2023
| Market size in 2022 |
US$ 2604.3 million
|
Forecast Market size by 2029 |
US$ 3520.9 million
|
| Growth Rate |
CAGR of 4.4% |
Number of Pages |
116 Pages |
Although opioids are very effective for treating and managing pain, their use frequently results in opioid-induced constipation (OIC). Treatment options for OIC may be as simple as changing diet or as complicated as requiring several medicines and laxatives.
This report aims to provide a comprehensive presentation of the global market for Opioid Induced Constipation Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opioid Induced Constipation Drugs. This report contains market size and forecasts of Opioid Induced Constipation Drugs in global, including the following market information:
Global Opioid Induced Constipation Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Opioid Induced Constipation Drugs Market Sales, 2018-2023, 2024-2029, (K Pcs)
Global top five Opioid Induced Constipation Drugs companies in 2022 (%)
The global Opioid Induced Constipation Drugs market was valued at US$ 2604.3 million in 2022 and is projected to reach US$ 3520.9 million by 2029, at a CAGR of 4.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Opioid-Induced Constipation key players include Sanofi, Bayer, Purdue Pharm, etc. Global top three manufacturers hold a share over 45%.
North America is the largest market, with a share about 55%, followed by Europe, and Asia-Pacific, both have a share about 35 percent.
In terms of product, Lubiprostone is the largest segment, with a share about 5%. And in terms of application, the largest application is Pharmacy, followed by Hospital, etc.
We surveyed the Opioid Induced Constipation Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Opioid Induced Constipation Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Opioid Induced Constipation Drugs Market Segment Percentages, by Type, 2022 (%)
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Others
Global Opioid Induced Constipation Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Opioid Induced Constipation Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Opioid Induced Constipation Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Opioid Induced Constipation Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Opioid Induced Constipation Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Opioid Induced Constipation Drugs revenues share in global market, 2022 (%)
Key companies Opioid Induced Constipation Drugs sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Opioid Induced Constipation Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc
Shionogi & Co., Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co., Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Bausch Health
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Opioid Induced Constipation Drugs, market overview.
Chapter 2: Global Opioid Induced Constipation Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Opioid Induced Constipation Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Opioid Induced Constipation Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Opioid Induced Constipation Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Opioid Induced Constipation Drugs Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 2604.3 million
|
| Forecast Market size by 2029 |
US$ 3520.9 million
|
| Growth Rate |
CAGR of 4.4% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
116 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Opioid Induced Constipation Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Opioid Induced Constipation Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Opioid Induced Constipation Drugs Overall Market Size
2.1 Global Opioid Induced Constipation Drugs Market Size: 2022 VS 2029
2.2 Global Opioid Induced Constipation Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Opioid Induced Constipation Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Opioid Induced Constipation Drugs Players in Global Market
3.2 Top Global Opioid Induced Constipation Drugs Companies Ranked by Revenue
3.3 Global Opioid Induced Constipation Drugs Revenue by Companies
3.4 Global Opioid Induced Constipation Drugs Sales by Companies
3.5 Global Opioid Induced Constipation Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Opioid Induced Constipation Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Opioid Induced Constipation Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Opioid Induced Constipation Drugs Players in Global Market
3.8.1 List of Global Tier 1 Opioid Induced Constipation Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Opioid Induced Constipation Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Opioid Induced Constipation Drugs Market Size Markets, 2022 & 2029
4.1.2 Lubiprostone
4.1.3 Methyl Naltrexone Bromide
4.1.4 Naldemedine
4.1.5 Alvimopan
4.1.6 Others
4.2 By Type - Global Opioid Induced Constipation Drugs Revenue & Forecasts
4.2.1 By Type - Global Opioid Induced Constipation Drugs Revenue, 2018-2023
4.2.2 By Type - Global Opioid Induced Constipation Drugs Revenue, 2024-2029
4.2.3 By Type - Global Opioid Induced Constipation Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Opioid Induced Constipation Drugs Sales & Forecasts
4.3.1 By Type - Global Opioid Induced Constipation Drugs Sales, 2018-2023
4.3.2 By Type - Global Opioid Induced Constipation Drugs Sales, 2024-2029
4.3.3 By Type - Global Opioid Induced Constipation Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Opioid Induced Constipation Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Opioid Induced Constipation Drugs Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Opioid Induced Constipation Drugs Revenue & Forecasts
5.2.1 By Application - Global Opioid Induced Constipation Drugs Revenue, 2018-2023
5.2.2 By Application - Global Opioid Induced Constipation Drugs Revenue, 2024-2029
5.2.3 By Application - Global Opioid Induced Constipation Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Opioid Induced Constipation Drugs Sales & Forecasts
5.3.1 By Application - Global Opioid Induced Constipation Drugs Sales, 2018-2023
5.3.2 By Application - Global Opioid Induced Constipation Drugs Sales, 2024-2029
5.3.3 By Application - Global Opioid Induced Constipation Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Opioid Induced Constipation Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Opioid Induced Constipation Drugs Market Size, 2022 & 2029
6.2 By Region - Global Opioid Induced Constipation Drugs Revenue & Forecasts
6.2.1 By Region - Global Opioid Induced Constipation Drugs Revenue, 2018-2023
6.2.2 By Region - Global Opioid Induced Constipation Drugs Revenue, 2024-2029
6.2.3 By Region - Global Opioid Induced Constipation Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Opioid Induced Constipation Drugs Sales & Forecasts
6.3.1 By Region - Global Opioid Induced Constipation Drugs Sales, 2018-2023
6.3.2 By Region - Global Opioid Induced Constipation Drugs Sales, 2024-2029
6.3.3 By Region - Global Opioid Induced Constipation Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Opioid Induced Constipation Drugs Revenue, 2018-2029
6.4.2 By Country - North America Opioid Induced Constipation Drugs Sales, 2018-2029
6.4.3 US Opioid Induced Constipation Drugs Market Size, 2018-2029
6.4.4 Canada Opioid Induced Constipation Drugs Market Size, 2018-2029
6.4.5 Mexico Opioid Induced Constipation Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Opioid Induced Constipation Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Opioid Induced Constipation Drugs Sales, 2018-2029
6.5.3 Germany Opioid Induced Constipation Drugs Market Size, 2018-2029
6.5.4 France Opioid Induced Constipation Drugs Market Size, 2018-2029
6.5.5 U.K. Opioid Induced Constipation Drugs Market Size, 2018-2029
6.5.6 Italy Opioid Induced Constipation Drugs Market Size, 2018-2029
6.5.7 Russia Opioid Induced Constipation Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Opioid Induced Constipation Drugs Market Size, 2018-2029
6.5.9 Benelux Opioid Induced Constipation Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Opioid Induced Constipation Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Opioid Induced Constipation Drugs Sales, 2018-2029
6.6.3 China Opioid Induced Constipation Drugs Market Size, 2018-2029
6.6.4 Japan Opioid Induced Constipation Drugs Market Size, 2018-2029
6.6.5 South Korea Opioid Induced Constipation Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Opioid Induced Constipation Drugs Market Size, 2018-2029
6.6.7 India Opioid Induced Constipation Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Opioid Induced Constipation Drugs Revenue, 2018-2029
6.7.2 By Country - South America Opioid Induced Constipation Drugs Sales, 2018-2029
6.7.3 Brazil Opioid Induced Constipation Drugs Market Size, 2018-2029
6.7.4 Argentina Opioid Induced Constipation Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Opioid Induced Constipation Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Opioid Induced Constipation Drugs Sales, 2018-2029
6.8.3 Turkey Opioid Induced Constipation Drugs Market Size, 2018-2029
6.8.4 Israel Opioid Induced Constipation Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Opioid Induced Constipation Drugs Market Size, 2018-2029
6.8.6 UAE Opioid Induced Constipation Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Ironwood Pharmaceuticals Inc
7.1.1 Ironwood Pharmaceuticals Inc Company Summary
7.1.2 Ironwood Pharmaceuticals Inc Business Overview
7.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Major Product Offerings
7.1.4 Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Ironwood Pharmaceuticals Inc Key News & Latest Developments
7.2 Daiichi Sankyo Co Ltd
7.2.1 Daiichi Sankyo Co Ltd Company Summary
7.2.2 Daiichi Sankyo Co Ltd Business Overview
7.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Major Product Offerings
7.2.4 Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Daiichi Sankyo Co Ltd Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Opioid Induced Constipation Drugs Major Product Offerings
7.3.4 Pfizer Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Progenics Pharmaceuticals Inc
7.4.1 Progenics Pharmaceuticals Inc Company Summary
7.4.2 Progenics Pharmaceuticals Inc Business Overview
7.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Major Product Offerings
7.4.4 Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Progenics Pharmaceuticals Inc Key News & Latest Developments
7.5 Shionogi & Co., Ltd
7.5.1 Shionogi & Co., Ltd Company Summary
7.5.2 Shionogi & Co., Ltd Business Overview
7.5.3 Shionogi & Co., Ltd Opioid Induced Constipation Drugs Major Product Offerings
7.5.4 Shionogi & Co., Ltd Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Shionogi & Co., Ltd Key News & Latest Developments
7.6 Allergan Plc
7.6.1 Allergan Plc Company Summary
7.6.2 Allergan Plc Business Overview
7.6.3 Allergan Plc Opioid Induced Constipation Drugs Major Product Offerings
7.6.4 Allergan Plc Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Allergan Plc Key News & Latest Developments
7.7 Nektar Therapeutics
7.7.1 Nektar Therapeutics Company Summary
7.7.2 Nektar Therapeutics Business Overview
7.7.3 Nektar Therapeutics Opioid Induced Constipation Drugs Major Product Offerings
7.7.4 Nektar Therapeutics Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Nektar Therapeutics Key News & Latest Developments
7.8 Purdue Pharma
7.8.1 Purdue Pharma Company Summary
7.8.2 Purdue Pharma Business Overview
7.8.3 Purdue Pharma Opioid Induced Constipation Drugs Major Product Offerings
7.8.4 Purdue Pharma Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Purdue Pharma Key News & Latest Developments
7.9 S.L.A. Pharma AG
7.9.1 S.L.A. Pharma AG Company Summary
7.9.2 S.L.A. Pharma AG Business Overview
7.9.3 S.L.A. Pharma AG Opioid Induced Constipation Drugs Major Product Offerings
7.9.4 S.L.A. Pharma AG Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.9.5 S.L.A. Pharma AG Key News & Latest Developments
7.10 Mundipharma International Limited
7.10.1 Mundipharma International Limited Company Summary
7.10.2 Mundipharma International Limited Business Overview
7.10.3 Mundipharma International Limited Opioid Induced Constipation Drugs Major Product Offerings
7.10.4 Mundipharma International Limited Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Mundipharma International Limited Key News & Latest Developments
7.11 Ono Pharmaceutical Co., Ltd
7.11.1 Ono Pharmaceutical Co., Ltd Company Summary
7.11.2 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Business Overview
7.11.3 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Major Product Offerings
7.11.4 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Ono Pharmaceutical Co., Ltd Key News & Latest Developments
7.12 Takeda Pharmaceutical Company Limited
7.12.1 Takeda Pharmaceutical Company Limited Company Summary
7.12.2 Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Business Overview
7.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Major Product Offerings
7.12.4 Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Takeda Pharmaceutical Company Limited Key News & Latest Developments
7.13 Theravance Biopharma Inc
7.13.1 Theravance Biopharma Inc Company Summary
7.13.2 Theravance Biopharma Inc Opioid Induced Constipation Drugs Business Overview
7.13.3 Theravance Biopharma Inc Opioid Induced Constipation Drugs Major Product Offerings
7.13.4 Theravance Biopharma Inc Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Theravance Biopharma Inc Key News & Latest Developments
7.14 Bausch Health
7.14.1 Bausch Health Company Summary
7.14.2 Bausch Health Business Overview
7.14.3 Bausch Health Opioid Induced Constipation Drugs Major Product Offerings
7.14.4 Bausch Health Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Bausch Health Key News & Latest Developments
7.15 Cosmo Pharmaceuticals SA
7.15.1 Cosmo Pharmaceuticals SA Company Summary
7.15.2 Cosmo Pharmaceuticals SA Business Overview
7.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Major Product Offerings
7.15.4 Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.15.5 Cosmo Pharmaceuticals SA Key News & Latest Developments
7.16 Daewoong Pharmaceutical
7.16.1 Daewoong Pharmaceutical Company Summary
7.16.2 Daewoong Pharmaceutical Business Overview
7.16.3 Daewoong Pharmaceutical Opioid Induced Constipation Drugs Major Product Offerings
7.16.4 Daewoong Pharmaceutical Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.16.5 Daewoong Pharmaceutical Key News & Latest Developments
7.17 C.B. Fleet Company
7.17.1 C.B. Fleet Company Company Summary
7.17.2 C.B. Fleet Company Business Overview
7.17.3 C.B. Fleet Company Opioid Induced Constipation Drugs Major Product Offerings
7.17.4 C.B. Fleet Company Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.17.5 C.B. Fleet Company Key News & Latest Developments
7.18 Sucampo Pharmaceuticals
7.18.1 Sucampo Pharmaceuticals Company Summary
7.18.2 Sucampo Pharmaceuticals Business Overview
7.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Major Product Offerings
7.18.4 Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.18.5 Sucampo Pharmaceuticals Key News & Latest Developments
8 Global Opioid Induced Constipation Drugs Production Capacity, Analysis
8.1 Global Opioid Induced Constipation Drugs Production Capacity, 2018-2029
8.2 Opioid Induced Constipation Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Opioid Induced Constipation Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Opioid Induced Constipation Drugs Supply Chain Analysis
10.1 Opioid Induced Constipation Drugs Industry Value Chain
10.2 Opioid Induced Constipation Drugs Upstream Market
10.3 Opioid Induced Constipation Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Opioid Induced Constipation Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Opioid Induced Constipation Drugs in Global Market
Table 2. Top Opioid Induced Constipation Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Opioid Induced Constipation Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Opioid Induced Constipation Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Opioid Induced Constipation Drugs Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Opioid Induced Constipation Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Opioid Induced Constipation Drugs Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Opioid Induced Constipation Drugs Product Type
Table 9. List of Global Tier 1 Opioid Induced Constipation Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Opioid Induced Constipation Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Opioid Induced Constipation Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Opioid Induced Constipation Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Opioid Induced Constipation Drugs Sales (K Pcs), 2018-2023
Table 15. By Type - Global Opioid Induced Constipation Drugs Sales (K Pcs), 2024-2029
Table 16. By Application ? Global Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Opioid Induced Constipation Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Opioid Induced Constipation Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Opioid Induced Constipation Drugs Sales (K Pcs), 2018-2023
Table 20. By Application - Global Opioid Induced Constipation Drugs Sales (K Pcs), 2024-2029
Table 21. By Region ? Global Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Opioid Induced Constipation Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Opioid Induced Constipation Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Opioid Induced Constipation Drugs Sales (K Pcs), 2018-2023
Table 25. By Region - Global Opioid Induced Constipation Drugs Sales (K Pcs), 2024-2029
Table 26. By Country - North America Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Opioid Induced Constipation Drugs Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Opioid Induced Constipation Drugs Sales, (K Pcs), 2024-2029
Table 30. By Country - Europe Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Opioid Induced Constipation Drugs Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Opioid Induced Constipation Drugs Sales, (K Pcs), 2024-2029
Table 34. By Region - Asia Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Opioid Induced Constipation Drugs Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Opioid Induced Constipation Drugs Sales, (K Pcs), 2024-2029
Table 38. By Country - South America Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Opioid Induced Constipation Drugs Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Opioid Induced Constipation Drugs Sales, (K Pcs), 2024-2029
Table 42. By Country - Middle East & Africa Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Opioid Induced Constipation Drugs Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Opioid Induced Constipation Drugs Sales, (K Pcs), 2024-2029
Table 46. Ironwood Pharmaceuticals Inc Company Summary
Table 47. Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Product Offerings
Table 48. Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. Ironwood Pharmaceuticals Inc Key News & Latest Developments
Table 50. Daiichi Sankyo Co Ltd Company Summary
Table 51. Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Product Offerings
Table 52. Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Daiichi Sankyo Co Ltd Key News & Latest Developments
Table 54. Pfizer Company Summary
Table 55. Pfizer Opioid Induced Constipation Drugs Product Offerings
Table 56. Pfizer Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. Pfizer Key News & Latest Developments
Table 58. Progenics Pharmaceuticals Inc Company Summary
Table 59. Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Product Offerings
Table 60. Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. Progenics Pharmaceuticals Inc Key News & Latest Developments
Table 62. Shionogi & Co., Ltd Company Summary
Table 63. Shionogi & Co., Ltd Opioid Induced Constipation Drugs Product Offerings
Table 64. Shionogi & Co., Ltd Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. Shionogi & Co., Ltd Key News & Latest Developments
Table 66. Allergan Plc Company Summary
Table 67. Allergan Plc Opioid Induced Constipation Drugs Product Offerings
Table 68. Allergan Plc Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. Allergan Plc Key News & Latest Developments
Table 70. Nektar Therapeutics Company Summary
Table 71. Nektar Therapeutics Opioid Induced Constipation Drugs Product Offerings
Table 72. Nektar Therapeutics Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. Nektar Therapeutics Key News & Latest Developments
Table 74. Purdue Pharma Company Summary
Table 75. Purdue Pharma Opioid Induced Constipation Drugs Product Offerings
Table 76. Purdue Pharma Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. Purdue Pharma Key News & Latest Developments
Table 78. S.L.A. Pharma AG Company Summary
Table 79. S.L.A. Pharma AG Opioid Induced Constipation Drugs Product Offerings
Table 80. S.L.A. Pharma AG Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 81. S.L.A. Pharma AG Key News & Latest Developments
Table 82. Mundipharma International Limited Company Summary
Table 83. Mundipharma International Limited Opioid Induced Constipation Drugs Product Offerings
Table 84. Mundipharma International Limited Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 85. Mundipharma International Limited Key News & Latest Developments
Table 86. Ono Pharmaceutical Co., Ltd Company Summary
Table 87. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Product Offerings
Table 88. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 89. Ono Pharmaceutical Co., Ltd Key News & Latest Developments
Table 90. Takeda Pharmaceutical Company Limited Company Summary
Table 91. Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Product Offerings
Table 92. Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 93. Takeda Pharmaceutical Company Limited Key News & Latest Developments
Table 94. Theravance Biopharma Inc Company Summary
Table 95. Theravance Biopharma Inc Opioid Induced Constipation Drugs Product Offerings
Table 96. Theravance Biopharma Inc Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 97. Theravance Biopharma Inc Key News & Latest Developments
Table 98. Bausch Health Company Summary
Table 99. Bausch Health Opioid Induced Constipation Drugs Product Offerings
Table 100. Bausch Health Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 101. Bausch Health Key News & Latest Developments
Table 102. Cosmo Pharmaceuticals SA Company Summary
Table 103. Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Product Offerings
Table 104. Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 105. Cosmo Pharmaceuticals SA Key News & Latest Developments
Table 106. Daewoong Pharmaceutical Company Summary
Table 107. Daewoong Pharmaceutical Opioid Induced Constipation Drugs Product Offerings
Table 108. Daewoong Pharmaceutical Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 109. Daewoong Pharmaceutical Key News & Latest Developments
Table 110. C.B. Fleet Company Company Summary
Table 111. C.B. Fleet Company Opioid Induced Constipation Drugs Product Offerings
Table 112. C.B. Fleet Company Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 113. C.B. Fleet Company Key News & Latest Developments
Table 114. Sucampo Pharmaceuticals Company Summary
Table 115. Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Product Offerings
Table 116. Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 117. Sucampo Pharmaceuticals Key News & Latest Developments
Table 118. Opioid Induced Constipation Drugs Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 119. Global Opioid Induced Constipation Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 120. Global Opioid Induced Constipation Drugs Production by Region, 2018-2023 (K Pcs)
Table 121. Global Opioid Induced Constipation Drugs Production by Region, 2024-2029 (K Pcs)
Table 122. Opioid Induced Constipation Drugs Market Opportunities & Trends in Global Market
Table 123. Opioid Induced Constipation Drugs Market Drivers in Global Market
Table 124. Opioid Induced Constipation Drugs Market Restraints in Global Market
Table 125. Opioid Induced Constipation Drugs Raw Materials
Table 126. Opioid Induced Constipation Drugs Raw Materials Suppliers in Global Market
Table 127. Typical Opioid Induced Constipation Drugs Downstream
Table 128. Opioid Induced Constipation Drugs Downstream Clients in Global Market
Table 129. Opioid Induced Constipation Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Opioid Induced Constipation Drugs Segment by Type in 2022
Figure 2. Opioid Induced Constipation Drugs Segment by Application in 2022
Figure 3. Global Opioid Induced Constipation Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Opioid Induced Constipation Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Opioid Induced Constipation Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Opioid Induced Constipation Drugs Sales in Global Market: 2018-2029 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Opioid Induced Constipation Drugs Revenue in 2022
Figure 9. By Type - Global Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Opioid Induced Constipation Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Opioid Induced Constipation Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Opioid Induced Constipation Drugs Price (USD/Pcs), 2018-2029
Figure 13. By Application - Global Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Opioid Induced Constipation Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Opioid Induced Constipation Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Opioid Induced Constipation Drugs Price (USD/Pcs), 2018-2029
Figure 17. By Region - Global Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Opioid Induced Constipation Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Opioid Induced Constipation Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Opioid Induced Constipation Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Opioid Induced Constipation Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Opioid Induced Constipation Drugs Sales Market Share, 2018-2029
Figure 23. US Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Opioid Induced Constipation Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Opioid Induced Constipation Drugs Sales Market Share, 2018-2029
Figure 28. Germany Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Opioid Induced Constipation Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Opioid Induced Constipation Drugs Sales Market Share, 2018-2029
Figure 37. China Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Opioid Induced Constipation Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Opioid Induced Constipation Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Opioid Induced Constipation Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Opioid Induced Constipation Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Opioid Induced Constipation Drugs Production Capacity (K Pcs), 2018-2029
Figure 53. The Percentage of Production Opioid Induced Constipation Drugs by Region, 2022 VS 2029
Figure 54. Opioid Induced Constipation Drugs Industry Value Chain
Figure 55. Marketing Channels
